Global Nasoenteric Feeding Tube Market Size By Type (Nasogastric Feeding Tubes, Nasojejunal Feeding Tubes), By Application (Oncology, Gastroenterology), By Region, And Segment Forecasts, 2023 to 2032

The Global Nasoenteric Feeding Tube Market was valued at USD 890 million in 2023 and is projected to reach USD 1.48 billion by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. This growth is primarily driven by the rising prevalence of chronic diseases requiring enteral nutrition, increased hospitalization rates among geriatric patients, and the growing awareness of early nutritional intervention in critical care settings. Nasoenteric feeding tubes, crucial for providing nutrition directly into the small intestine, are witnessing significant demand, especially in intensive care units (ICUs) and long-term care facilities.

Drivers:

Rising Incidence of Chronic and Critical Illnesses:

Patients suffering from neurological disorders, cancers, gastrointestinal surgeries, and severe trauma often require nasoenteric feeding for proper nutrient delivery. The increasing global burden of these conditions is driving the adoption of enteral feeding solutions.

Aging Global Population:

With the elderly population more prone to swallowing disorders (dysphagia) and chronic diseases, the demand for nasoenteric feeding tubes is growing, particularly in developed healthcare markets.

Increased ICU Admissions and Use in Post-Surgical Recovery:

Feeding tubes are essential for patients recovering from surgeries or those who are unconscious and unable to eat orally. As healthcare systems increasingly adopt enteral nutrition protocols, market penetration is expanding.

Restraints:

Risk of Complications and Tube Misplacement:

Despite their benefits, nasoenteric tubes can be associated with complications like infections, aspiration, and incorrect placement, which may lead to reluctance among healthcare professionals in their usage.

Limited Adoption in Low-Resource Settings:

High procedural costs, lack of trained personnel, and inadequate healthcare infrastructure in certain regions hinder market growth.

Opportunity:

Technological Advancements in Tube Design and Placement Techniques:

Innovations such as electromagnetic guidance systems, antimicrobial-coated tubes, and radiopaque materials are enhancing the safety and accuracy of nasoenteric feeding, opening new avenues for growth.

Emerging Markets and Home Healthcare Expansion:

The shift towards home-based enteral nutrition, coupled with expanding healthcare infrastructure in Asia-Pacific and Latin America, offers lucrative opportunities for manufacturers and service providers.

Market by System Type Insights:

Based on system type, Post-Pyloric Feeding Tubes dominated the market in 2023, driven by their usage in patients with a high risk of aspiration or delayed gastric emptying. These tubes ensure nutrient delivery directly into the small intestine, improving tolerance and outcomes. Meanwhile, Jejunal Feeding Tubes are expected to witness notable growth, especially in long-term care and oncology settings.

Market by End-use Insights:

In terms of end use, the Hospitals segment held the largest market share in 2023, accounting for over 50% of revenue. The widespread use of nasoenteric tubes in ICUs, surgical recovery units, and emergency care settings fuels this dominance. However, the Home Healthcare segment is anticipated to grow rapidly due to the increasing preference for outpatient nutrition therapy and cost-effective care models.

Market by Regional Insights:

North America led the global nasoenteric feeding tube market in 2023, backed by advanced healthcare infrastructure, higher awareness about clinical nutrition, and supportive reimbursement policies. Asia-Pacific, on the other hand, is expected to register the fastest growth, propelled by expanding healthcare access, rising chronic disease prevalence, and increased healthcare spending in countries like India and China.

Competitive Scenario:

Key players in the Global Nasoenteric Feeding Tube Market include Cardinal Health, Medtronic plc, Nestlé Health Science, Fresenius Kabi, B. Braun Melsungen AG, Avanos Medical Inc., Vygon SA, and Applied Medical Technology Inc. These companies are actively engaging in product innovation, geographic expansion, and strategic collaborations to solidify their market positions.

Scope of Work – Global Nasoenteric Feeding Tube Market

Report Metric Details

Market Size (2023) USD 890 million

Projected Market Size (2031) USD 1.48 billion

CAGR (2023–2031) 6.7%

Key Segments System Type (Post-Pyloric, Jejunal), End-Use

Growth Drivers Rising ICU admissions, aging population, chronic illness management

Opportunities Technological innovation, emerging markets, home healthcare

Key Market Developments:

2023: Medtronic plc introduced a next-gen nasoenteric tube with electromagnetic guidance for safer bedside placement.

2024: Fresenius Kabi partnered with home healthcare providers across Europe to expand access to enteral nutrition.

2025: Avanos Medical Inc. launched antimicrobial-coated tubes targeting infection prevention in long-term care settings.

FAQs:

1) What is the current market size of the Global Nasoenteric Feeding Tube Market?

As of 2023, the market is valued at USD 890 million.

2) What is the major growth driver of the Global Nasoenteric Feeding Tube Market?

The major driver is the rising incidence of chronic diseases and critical illnesses requiring enteral nutrition.

3) Which is the largest region during the forecast period in the Global Nasoenteric Feeding Tube Market?

North America is expected to maintain its dominance due to advanced clinical infrastructure and high ICU admissions.

4) Which segment accounted for the largest market share in the Global Nasoenteric Feeding Tube Market?

The Hospitals segment accounted for the largest share, owing to high usage in intensive and post-operative care.

5) Who are the key market players in the Global Nasoenteric Feeding Tube Market?

Key players include Medtronic plc, Cardinal Health, Fresenius Kabi, Avanos Medical Inc., Nestlé Health Science, and B. Braun Melsungen AG.